{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:40:20Z","timestamp":1787312420126,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:00:00Z","timestamp":1247184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:00:00Z","timestamp":1247184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Infusing arginine vasopressin (AVP) in vasodilatory shock usually decreases cardiac output and thus systemic oxygen transport. It is still a matter of debate whether this vasoconstriction impedes visceral organ blood flow and thereby causes organ dysfunction and injury. Therefore, we tested the hypothesis whether low-dose AVP is safe with respect to liver, kidney, and heart function and organ injury during resuscitated septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      After intraperitoneal inoculation of autologous feces, 24 anesthetized, mechanically ventilated, and instrumented pigs were randomly assigned to noradrenaline alone (increments of 0.05 \u03bcg\/kg\/min until maximal heart rate of 160 beats\/min; n = 12) or AVP (1 to 5 ng\/kg\/min; supplemented by noradrenaline if the maximal AVP dosage failed to maintain mean blood pressure; n = 12) to treat sepsis-associated hypotension. Parameters of systemic and regional hemodynamics (ultrasound flow probes on the portal vein and hepatic artery), oxygen transport, metabolism (endogenous glucose production and whole body glucose oxidation derived from blood glucose isotope and expiratory\n                      <jats:sup>13<\/jats:sup>\n                      CO\n                      <jats:sub>2<\/jats:sub>\n                      \/\n                      <jats:sup>12<\/jats:sup>\n                      CO\n                      <jats:sub>2<\/jats:sub>\n                      enrichment during 1,2,3,4,5,6-\n                      <jats:sup>13<\/jats:sup>\n                      C\n                      <jats:sub>6<\/jats:sub>\n                      -glucose infusion), visceral organ function (blood transaminase activities, bilirubin and creatinine concentrations, creatinine clearance, fractional Na\n                      <jats:sup>+<\/jats:sup>\n                      excretion), nitric oxide (exhaled NO and blood nitrate + nitrite levels) and cytokine production (interleukin-6 and tumor necrosis factor-\u03b1 blood levels), and myocardial function (left ventricular dp\/dt\n                      <jats:sub>max<\/jats:sub>\n                      and dp\/dt\n                      <jats:sub>min<\/jats:sub>\n                      ) and injury (troponin I blood levels) were measured before and 12, 18, and 24 hours after peritonitis induction. Immediate post mortem liver and kidney biopsies were analysed for histomorphology (hematoxylin eosin staining) and apoptosis (TUNEL staining).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AVP decreased heart rate and cardiac output without otherwise affecting heart function and significantly decreased troponin I blood levels. AVP increased the rate of direct, aerobic glucose oxidation and reduced hyperlactatemia, which coincided with less severe kidney dysfunction and liver injury, attenuated systemic inflammation, and decreased kidney tubular apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      During well-resuscitated septic shock low-dose AVP appears to be safe with respect to myocardial function and heart injury and reduces kidney and liver damage. It remains to be elucidated whether this is due to the treatment\n                      <jats:italic>per se<\/jats:italic>\n                      and\/or to the decreased exogenous catecholamine requirements.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/cc7959","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T14:50:42Z","timestamp":1247237442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Florian","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Scheuerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef A","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Georgieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gent","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Radermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Calzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,10]]},"reference":[{"key":"7390_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/cc2945","volume":"9","author":"A Delmas","year":"2005","unstructured":"Delmas A, Leone M, Rousseau S, Alban\u00e8se J, Martin C: Clinical review: Vasopressin and terlipressin in septic shock patients.\n                           Crit Care 2005, 9: 212-222. 10.1186\/cc2945","journal-title":"Crit Care"},{"key":"7390_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/cc5089","volume":"10","author":"MW D\u00fcnser","year":"2006","unstructured":"D\u00fcnser MW, Hasibeder WR: Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart!\n                           Crit Care 2006, 10: 172. 10.1186\/cc5089","journal-title":"Crit Care"},{"key":"7390_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/cc6171","volume":"11","author":"H Bracht","year":"2007","unstructured":"Bracht H, Asfar P, Radermacher P, Calzia E: Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?\n                           Crit Care 2007, 11: 178. 10.1186\/cc6171","journal-title":"Crit Care"},{"key":"7390_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/cc6839","volume":"12","author":"B Hauser","year":"2008","unstructured":"Hauser B, Asfar P, Calzia E, Laporte R, Georgieff M, Radermacher P: Vasopressin in vasodilatory shock: is the heart in danger?\n                           Crit Care 2008, 12: 132. 10.1186\/cc6839","journal-title":"Crit Care"},{"key":"7390_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/cc6850","volume":"12","author":"G Luckner","year":"2008","unstructured":"Luckner G, Hasibeder WR, D\u00fcnser MW: Vasopressor stays vasopressor and inotrope stays inotrope!\n                           Crit Care 2008, 12: 415. 10.1186\/cc6850","journal-title":"Crit Care"},{"key":"7390_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1213\/01.ANE.0000087039.60041.2E","volume":"97","author":"TJ Martikainen","year":"2003","unstructured":"Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E: The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock.\n                           Anesth Analg 2003, 97: 1756-1763. 10.1213\/01.ANE.0000087039.60041.2E","journal-title":"Anesth Analg"},{"key":"7390_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1152\/japplphysiol.00017.2003","volume":"95","author":"JA Guzman","year":"2003","unstructured":"Guzman JA, Rosado AE, Kruse JA: Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects.\n                           J Appl Physiol 2003, 95: 803-809.","journal-title":"J Appl Physiol"},{"key":"7390_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1164\/rccm.200205-447OC","volume":"168","author":"Q Sun","year":"2003","unstructured":"Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL: Low-dose vasopressin in the treatment of septic shock in sheep.\n                           Am J Respir Crit Care Med 2003, 168: 481-486. 10.1164\/rccm.200205-447OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7390_CR9","doi-asserted-by":"publisher","first-page":"H209","DOI":"10.1152\/ajpheart.00946.2003","volume":"287","author":"B Levy","year":"2004","unstructured":"Levy B, Vall\u00e9e C, Lauzier F, Plante GE, Mansart A, Mallie JP, Lesur O: Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock.\n                           Am J Physiol Heart Circ Physiol 2004, 287: H209-H215. 10.1152\/ajpheart.00946.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7390_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/01.CCM.0000128578.37822.F1","volume":"32","author":"MB Malay","year":"2004","unstructured":"Malay MB, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC Jr, Sciacca RR, Oliver JA, Landry DW: Hetergeneity of the vasoconstrictor effect of vasopressin in septic shock.\n                           Crit Care Med 2004, 32: 1327-1331. 10.1097\/01.CCM.0000128578.37822.F1","journal-title":"Crit Care Med"},{"key":"7390_CR11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/01.CCM.0000139708.10718.E3","volume":"32","author":"M Albert","year":"2004","unstructured":"Albert M, Losser MR, Hayon D, Faivre V, Payen D: Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits.\n                           Crit Care Med 2004, 32: 1891-1898. 10.1097\/01.CCM.0000139708.10718.E3","journal-title":"Crit Care Med"},{"key":"7390_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.CCM.0000104201.62736.12","volume":"32","author":"M Westphal","year":"2004","unstructured":"Westphal M, Freise H, Kehrel BE, Bone HG, Van Aken H, Sielenk\u00e4mper AW: Arginine vasopressin compromises gut mucosal microcirculation in septic rats.\n                           Crit Care Med 2004, 32: 194-200. 10.1097\/01.CCM.0000104201.62736.12","journal-title":"Crit Care Med"},{"key":"7390_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0310057X0603400408","volume":"34","author":"D Di Giantomasso","year":"2006","unstructured":"Di Giantomasso D, Morimatsu H, Bellomo R, May CN: Effect of low-dose vasopressin infusion on vital organ blood flow in the conscious normal and septic sheep.\n                           Anaesth Intensive Care 2006, 34: 427-433.","journal-title":"Anaesth Intensive Care"},{"key":"7390_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00134-005-2858-z","volume":"32","author":"H Knotzer","year":"2006","unstructured":"Knotzer H, Maier S, D\u00fcnser MW, Hasibeder WR, Hausdorfer H, Brandner J, Torgersen C, Ulmer H, Friesenecker B, Iannetti C, Pajk W: Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model.\n                           Intensive Care Med 2006, 32: 170-174. 10.1007\/s00134-005-2858-z","journal-title":"Intensive Care Med"},{"key":"7390_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/01.anes.0000267599.02140.86","volume":"106","author":"LB Hiltebrand","year":"2007","unstructured":"Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH: Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock.\n                           Anesthesiology 2007, 106: 1156-1167. 10.1097\/01.anes.0000267599.02140.86","journal-title":"Anesthesiology"},{"key":"7390_CR16","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/cc6197","volume":"11","author":"V Krejci","year":"2007","unstructured":"Krejci V, Hiltebrand LB, Jakob SM, Takala J, Sigurdsson GH: Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow.\n                           Crit Care 2007, 11: R129. 10.1186\/cc6197","journal-title":"Crit Care"},{"key":"7390_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00134-008-1058-z","volume":"34","author":"T Kopel","year":"2008","unstructured":"Kopel T, Losser MR, Faivre V, Payen D: Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.\n                           Intensive Care Med 2008, 34: 1313-1320. 10.1007\/s00134-008-1058-z","journal-title":"Intensive Care Med"},{"key":"7390_CR18","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/cc6794","volume":"12","author":"S M\u00fcller","year":"2008","unstructured":"M\u00fcller S, How OJ, Hermansen SE, Stenberg TA, Sager G, Myrmel T: Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia.\n                           Crit Care 2008, 12: R20. 10.1186\/cc6794","journal-title":"Crit Care"},{"key":"7390_CR19","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s00134-009-1470-z","volume":"35","author":"S Rehberg","year":"2009","unstructured":"Rehberg S, Ertmer C, K\u00f6hler G, Spiegel HU, Morelli A, Lange M, Moll K, Schlack K, Van Aken H, Su F, Vincent JL, Westphal M: Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.\n                           Intensive Care Med 2009, 35: 1286-1296. 10.1007\/s00134-009-1470-z","journal-title":"Intensive Care Med"},{"key":"7390_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR: Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.\n                           Circulation 2003, 107: 2313-2319. 10.1161\/01.CIR.0000066692.71008.BB","journal-title":"Circulation"},{"key":"7390_CR21","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","volume":"31","author":"S Klinzing","year":"2003","unstructured":"Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A: High-dose vasopressin is not superior to norepinephrine in septic shock.\n                           Crit Care Med 2003, 31: 2646-2650. 10.1097\/01.CCM.0000094260.05266.F4","journal-title":"Crit Care Med"},{"key":"7390_CR22","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","volume":"32","author":"F Lauzier","year":"2006","unstructured":"Lauzier F, L\u00e9vy B, Lamarre P, Lesur O: Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.\n                           Intensive Care Med 2006, 32: 1782-1789. 10.1007\/s00134-006-0378-0","journal-title":"Intensive Care Med"},{"key":"7390_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00000658-198004000-00017","volume":"191","author":"MF Wilson","year":"1980","unstructured":"Wilson MF, Brackett DJ, Archer LT, Hinshaw LB: Mechanisms of impaired cardiac function by vasopressin.\n                           Ann Surg 1980, 191: 494-500. 10.1097\/00000658-198004000-00017","journal-title":"Ann Surg"},{"key":"7390_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00000542-200501000-00016","volume":"102","author":"A Ouattara","year":"2005","unstructured":"Ouattara A, Landi M, Le Manach Y, Lecomte P, Leguen M, Boccara G, Coriat P, Riou B: Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart.\n                           Anesthesiology 2005, 102: 85-92. 10.1097\/00000542-200501000-00016","journal-title":"Anesthesiology"},{"key":"7390_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/00000542-200509000-00014","volume":"103","author":"V Faivre","year":"2005","unstructured":"Faivre V, Kaskos H, Callebert J, Losser MR, Milliez P, Bonnin P, Payen D, Mebazaa A: Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits.\n                           Anesthesiology 2005, 103: 514-521. 10.1097\/00000542-200509000-00014","journal-title":"Anesthesiology"},{"key":"7390_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1399-6576.1997.tb04708.x","volume":"41","author":"BM Graf","year":"1997","unstructured":"Graf BM, Fischer B, Stowe DF, Bosnjak ZJ, Martin EO: Synthetic 8-ornithine vasopressin, a clinically used vasoconstrictor, causes cardiac effects mainly via changes in coronary flow.\n                           Acta Anaesthesiol Scand 1997, 41: 414-421. 10.1111\/j.1399-6576.1997.tb04708.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"7390_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russel","year":"2008","unstructured":"Russel JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock.\n                           N Engl J Med 2008, 358: 877-887. 10.1056\/NEJMoa067373","journal-title":"N Engl J Med"},{"key":"7390_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.CCM.0B013E318161FC45","volume":"36","author":"E Barth","year":"2008","unstructured":"Barth E, Bassi G, Maybauer DM, Simon F, Gr\u00f6ger M, Oter S, Speit G, Nguyen CD, Hasel C, M\u00f6ller P, Wachter U, Vogt JA, Matejovic M, Radermacher P, Calzia E: Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis.\n                           Crit Care Med 2008, 36: 495-503. 10.1097\/01.CCM.0B013E318161FC45","journal-title":"Crit Care Med"},{"key":"7390_CR29","doi-asserted-by":"publisher","first-page":"S609","DOI":"10.1097\/01.CCM.0000279158.51481.41","volume":"35","author":"JA Russell","year":"2007","unstructured":"Russell JA: Vasopressin in septic shock.\n                           Crit Care Med 2007, 35: S609-615. 10.1097\/01.CCM.0000279158.51481.41","journal-title":"Crit Care Med"},{"key":"7390_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0022-2828(85)80130-9","volume":"17","author":"G Rona","year":"1985","unstructured":"Rona G: Catecholamine cardiotoxycity.\n                           J Mol Cell Cardiol 1985, 17: 291-306. 10.1016\/S0022-2828(85)80130-9","journal-title":"J Mol Cell Cardiol"},{"key":"7390_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0167-5273(94)90051-5","volume":"45","author":"A Movahed","year":"1994","unstructured":"Movahed A, Reeves WC, Mehta PM, Gilliland MG, Mozingo SL, Jolly SR: Norepinephrine-induced left ventricular dysfunction in anesthetized and conscious, sedated dogs.\n                           Int J Cardiol 1994, 45: 23-33. 10.1016\/0167-5273(94)90051-5","journal-title":"Int J Cardiol"},{"key":"7390_CR32","doi-asserted-by":"crossref","first-page":"H1345","DOI":"10.1152\/ajpheart.2000.278.4.H1345","volume":"278","author":"C Korvald","year":"2000","unstructured":"Korvald C, Elvenes OP, Myrmel T: Myocardial substrate metabolism influences left ventricular energetics\n                           in vivo\n                           .\n                           Am J Physiol Heart Circ Physiol 2000, 278: H1345-H1351.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7390_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.CCM.0000152253.45901.FB","volume":"33","author":"P Asfar","year":"2005","unstructured":"Asfar P, Hauser B, Iv\u00e1nyi Z, Ehrmann U, Kick J, Albicini M, Vogt J, Wachter U, Br\u00fcckner UB, Radermacher P, Bracht H: Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism.\n                           Crit Care Med 2005, 33: 373-380. 10.1097\/01.CCM.0000152253.45901.FB","journal-title":"Crit Care Med"},{"key":"7390_CR34","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1097\/CCM.0b013e318186a938","volume":"36","author":"F Chagnon","year":"2008","unstructured":"Chagnon F, Vaidya VS, Plante GE, Bonventre JV, Bernard A, Guindi C, Lesur O: Modulation of aquaporin-2\/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.\n                           Crit Care Med 2008, 36: 3054-3061. 10.1097\/CCM.0b013e318186a938","journal-title":"Crit Care Med"},{"key":"7390_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/02844318309007176","volume":"17","author":"E Vernersson","year":"1983","unstructured":"Vernersson E, Ahlgren I, Aronsen KF: Effects of lysine-vasopressin treatment on renal function in burned pigs.\n                           Scand J Plast Reconstr 1983, 17: 25-31. 10.3109\/02844318309007176","journal-title":"Scand J Plast Reconstr"},{"key":"7390_CR36","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","volume":"96","author":"BM Patel","year":"2002","unstructured":"Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock.\n                           Anesthesiology 2002, 96: 576-582. 10.1097\/00000542-200203000-00011","journal-title":"Anesthesiology"},{"key":"7390_CR37","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1439-0442.1990.tb00969.x","volume":"37","author":"M Wendt","year":"1990","unstructured":"Wendt M, Waldmann KH, Bickhardt K: [Comparative studies of the clearance of inulin and creatinine in swine].\n                           Zentralbl Veterin\u00e4rmed A 1990, 37: 752-759.","journal-title":"Zentralbl Veterin\u00e4rmed A"},{"key":"7390_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/00000542-200609000-00026","volume":"105","author":"TA Treschan","year":"2006","unstructured":"Treschan TA, Peters J: The vasopressin system: physiology and clinical strategies.\n                           Anesthesiology 2006, 105: 599-612. 10.1097\/00000542-200609000-00026","journal-title":"Anesthesiology"},{"key":"7390_CR39","first-page":"F290","volume":"251","author":"KP Conrad","year":"1986","unstructured":"Conrad KP, Gellai M, North WG, Valtin H: Influence of oxytocin on renal hemodynamics and eletrolyte and water excretion.\n                           Am J Physiol 1986, 251: F290-F296.","journal-title":"Am J Physiol"},{"key":"7390_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/cs0700409","volume":"70","author":"JJ Dixey","year":"1986","unstructured":"Dixey JJ, Willimas TD, Lightman SL, Lant AF, Brewerton DA: The effect of indomethacin on the renal response to arginine vasopressin in man.\n                           Clin Sci 1986, 70: 409-416.","journal-title":"Clin Sci"},{"key":"7390_CR41","first-page":"125","volume":"19","author":"KJ Gibson","year":"1993","unstructured":"Gibson KJ, Lumbers ER: The roles of arginine vasopressin in fetal sodium balance and as a mediator of the effects of fetal 'stress'.\n                           J Dev Physiol 1993, 19: 125-136.","journal-title":"J Dev Physiol"},{"key":"7390_CR42","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1139\/y87-351","volume":"65","author":"J Krayacich","year":"1987","unstructured":"Krayacich J, Kline RL, Mercer PF: Supersensititivy to norepinephrine in chronically denervated kidneys: evidence for a postsynaptic effect.\n                           Can J Physiol Pharmacol 1987, 65: 2219-2224.","journal-title":"Can J Physiol Pharmacol"},{"key":"7390_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1042\/cs0850487","volume":"85","author":"CC Lang","year":"1993","unstructured":"Lang CC, Rahman AR, Balfour DJ, Struthers AD: Effect of noradrenaline onr enal sodium and water handling in euhydrated and overhydrated man.\n                           Clin Sci 1993, 85: 487-494.","journal-title":"Clin Sci"},{"key":"7390_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.resuscitation.2008.07.006","volume":"79","author":"JH Boyd","year":"2008","unstructured":"Boyd JH, Holmes CL, Wang Y, Roberts H, Walley KR: Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R.\n                           Resuscitation 2008, 79: 325-331. 10.1016\/j.resuscitation.2008.07.006","journal-title":"Resuscitation"},{"key":"7390_CR45","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/jhep.2002.36501","volume":"36","author":"R Moreau","year":"2002","unstructured":"Moreau R, Barri\u00e8re E, Tazi KA, Lardeux B, Darg\u00e8re D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D, Lebrec D: Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.\n                           Hepatology 2002, 36: 1070-1078. 10.1053\/jhep.2002.36501","journal-title":"Hepatology"},{"key":"7390_CR46","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/CCM.0B013E31816532BE","volume":"36","author":"C Aninat","year":"2008","unstructured":"Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A: Catecholamines induce an inflammatory response in human hepatocytes.\n                           Crit Care Med 2008, 36: 848-854. 10.1097\/CCM.0B013E31816532BE","journal-title":"Crit Care Med"},{"key":"7390_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.shk.0000095934.86703.83","volume":"20","author":"M Bergmann","year":"2003","unstructured":"Bergmann M, Gornikiewicz A, Tamandl D, Exner R, Roth E, F\u00fcgger R, G\u00f6tzinger P, Sautner T: Continuous therapeutic epinephrine but not norepinephrine prolongs splanchnic IL-6 production in porcine endotoxic shock.\n                           Shock 2003, 20: 575-581. 10.1097\/01.shk.0000095934.86703.83","journal-title":"Shock"},{"key":"7390_CR48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nature06185","volume":"449","author":"MA Flierl","year":"2007","unstructured":"Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR, Ward PA: Phagocyte-derived catecholamines enhance acute inflammatory injury.\n                           Nature 2007, 449: 721-725. 10.1038\/nature06185","journal-title":"Nature"},{"issue":"9 Suppl","key":"7390_CR49","doi-asserted-by":"publisher","first-page":"S454","DOI":"10.1097\/01.CCM.0000278044.19217.73","volume":"35","author":"XM Leverve","year":"2007","unstructured":"Leverve XM: Mitochondrial function and substrate availability.\n                           Crit Care Med. 2007,35(9 Suppl):S454-S460. 10.1097\/01.CCM.0000278044.19217.73","journal-title":"Crit Care Med"},{"key":"7390_CR50","first-page":"S508","volume-title":"Crit Care Med","author":"E Barth","year":"2007","unstructured":"Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, Radermacher P, Calzia E: Glucose metabolism and catecholamines.\n                           Crit Care Med 2007, S508-S518. 10.1097\/01.CCM.0000278047.06965.20"},{"key":"7390_CR51","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/cc6956","volume":"12","author":"T Regueria","year":"2008","unstructured":"Regueria T, B\u00e4nziger B, Djafarzadeh S, Brandt S, Gorrasi J, Takala J, Lepper PM, Jakob SM: Norepinephrine to increase blood pressure in endotoxemic pigs is associated with improved hepatic mitochondrial respiration.\n                           Crit Care 2008, 12: R88. 10.1186\/cc6956","journal-title":"Crit Care"},{"key":"7390_CR52","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0140-6736(07)61317-8","volume":"370","author":"M Singer","year":"2007","unstructured":"Singer M: Catecholamine treatment for shock \u2013 equally good or bad?\n                           Lancet 2007, 370: 636-637. 10.1016\/S0140-6736(07)61317-8","journal-title":"Lancet"},{"key":"7390_CR53","first-page":"650","volume":"3","author":"AD Bersten","year":"1995","unstructured":"Bersten AD, Holt AW: Vasoactive drugs and the importance of renal perfusion pressure.\n                           New Horiz 1995, 3: 650-661.","journal-title":"New Horiz"},{"key":"7390_CR54","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1097\/00003246-200008000-00007","volume":"28","author":"D LeDoux","year":"2000","unstructured":"LeDoux D, Astiz ME, Carpati CM, Rackow EC: Effects of perfusion pressure on tissue perfusion in septic shock.\n                           Crit Care Med 2000, 28: 2729-2732. 10.1097\/00003246-200008000-00007","journal-title":"Crit Care Med"},{"key":"7390_CR55","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/01.CCM.0000157788.20591.23","volume":"33","author":"A Bourgoin","year":"2005","unstructured":"Bourgoin A, Leone M, Delmas A, Garnier F, Alban\u00e8se J, Martin C: Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function.\n                           Crit Care Med 2005, 33: 780-786. 10.1097\/01.CCM.0000157788.20591.23","journal-title":"Crit Care Med"},{"key":"7390_CR56","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/01.shk.0000245026.01365.55","volume":"27","author":"CB Margarido","year":"2007","unstructured":"Margarido CB, Margarido NF, Otsuki DA, Fantoni DT, Marumo CK, Kitahara FR, Magalh\u00e3es AA, Pasqualucci CA, Auler JO: Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution.\n                           Shock 2007, 27: 390-396. 10.1097\/01.shk.0000245026.01365.55","journal-title":"Shock"},{"key":"7390_CR57","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1097\/01.CCM.0000242755.74063.ED","volume":"34","author":"G Marx","year":"2006","unstructured":"Marx G, Pedder S, Smith L, Swaraj S, Grime S, Stockdale H, Leuwer M: Attenuation of capillary leakage by hydroxyethyl starch (130\/0.42) in a porcine model of septic shock.\n                           Crit Care Med 2006, 34: 3005-3010.","journal-title":"Crit Care Med"},{"key":"7390_CR58","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/cc7726","volume":"13","author":"L H\u00fcter","year":"2009","unstructured":"H\u00fcter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G: Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model.\n                           Crit Care 2009, 13: R23. 10.1186\/cc7726","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc7959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc7959\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc7959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T08:40:03Z","timestamp":1728290403000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc7959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,10]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,8]]}},"alternative-id":["7390"],"URL":"https:\/\/doi.org\/10.1186\/cc7959","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1163350.625059","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,10]]},"assertion":[{"value":"18 June 2009","order":1,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R113"}}